{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:08:04Z","timestamp":1794002884443,"version":"4.8.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>Transfusion of blood products is a common lifesaving medical procedure in clinical practice. However, it poses the risk of potential adverse reactions for the recipient. Transfusion-associated graft-versus-host-disease (TA-GVHD) is a rare adverse event, fatal in &gt;90% of cases. TA-GVHD pathophysiology is not completely understood involving two factors: (i) underlying immunosuppression and (ii) human leukocyte antigen compatibility between blood donor and recipient. Clinical presentation is not specific, and the difficulty in correlating the clinical syndrome to the transfusion renders diagnosis challenging. As no effective treatment exists to date, irradiation of blood products remains the cornerstone of TA-GVHD prevention. Distinct differences emerge in comparing TA-GVHD to GVHD, a common event of the bone marrow graft to the recipient after allogeneic hematopoietic stem cell transplantation; thus, GVHD may be a helpful disease model used to better understand TA-GVHD. This is a review of TA-GVHD in comparison with GVHD.<\/jats:p>","DOI":"10.4103\/hemoncstem.hemoncstem-d-24-00043","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T03:00:15Z","timestamp":1737342015000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Transfusion-associated graft-versus-host disease (TA-GVHD) and graft-versus-host disease (GVHD): Pathophysiology and management (contrasted and compared)"],"prefix":"10.4103","volume":"17","author":[{"given":"Serena","family":"Valsami","sequence":"first","affiliation":[{"name":"Hematology Laboratory-Blood Bank, Aretaieion Hospital, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Dryllis","sequence":"additional","affiliation":[{"name":"Laboratory of Reliability and Quality Control in Laboratory Haematology (HemoQcR), Department of Biomedical Sciences, School of Health & Welfare Sciences, University of West Attica (UniWA), Egaleo City, Greece"},{"name":"Department of Clinical Hematology, \u201cMitera\u201d Hospital of Athens, Marousi 15123, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassiani","family":"Papanastasi","sequence":"additional","affiliation":[{"name":"Hematology Laboratory-Blood Bank, Aretaieion Hospital, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Kokoris","sequence":"additional","affiliation":[{"name":"Laboratory of Haematology and Blood Bank Unit, \"Attiko\" Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Kriebardis","sequence":"additional","affiliation":[{"name":"Laboratory of Reliability and Quality Control in Laboratory Haematology (HemoQcR), Department of Biomedical Sciences, School of Health & Welfare Sciences, University of West Attica (UniWA), Egaleo City, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Nikitiadis","sequence":"additional","affiliation":[{"name":"Hematology Laboratory-Blood Bank, Aretaieion Hospital, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Konstantopoulos","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology, \u201cMitera\u201d Hospital of Athens, Marousi 15123, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Politou","sequence":"additional","affiliation":[{"name":"Hematology Laboratory-Blood Bank, Aretaieion Hospital, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"R1-20250123","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJM196510282731803","article-title":"Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children","volume":"273","author":"Hathaway","year":"1965","journal-title":"Probable human runt disease. N Engl J Med"},{"key":"R2-20250123","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJM196909252811303","article-title":"Possible graft-versus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis","volume":"281","author":"Naiman","year":"1969","journal-title":"N Engl J Med"},{"key":"R3-20250123","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM199002013220507","article-title":"Transfusion-associated graft-versus-host disease","volume":"323","author":"Anderson","year":"1990","journal-title":"N Engl J Med"},{"key":"R4-20250123","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1423-0410.2008.01073.x","article-title":"Transfusion-associated graft-versus-host disease","volume":"95","author":"Dwyre","year":"2008","journal-title":"Vox Sanguinis"},{"key":"R5-20250123","doi-asserted-by":"crossref","first-page":"1079708","DOI":"10.3389\/fimmu.2022.1079708","article-title":"Milestones in acute GVHD pathophysiology","volume":"13","author":"Socie","year":"2022","journal-title":"Front Immunol"},{"key":"R6-20250123","doi-asserted-by":"crossref","first-page":"662","DOI":"10.5858\/arpa.2016-0620-RS","article-title":"Prevention of transfusion-associated graft-versus-host disease with blood product irradiation: the past, present, and future","volume":"142","author":"Bahar","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R7-20250123","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1537-2995.1995.35495216075.x","article-title":"Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes","volume":"35","author":"Wagner","year":"1995","journal-title":"Transfusion"},{"key":"R8-20250123","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bjh.17015","article-title":"Guidelines on the use of irradiated blood components","volume":"191","author":"Foukaneli","year":"2020","journal-title":"Br J Haematol"},{"key":"R9-20250123","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/0885066613492645","article-title":"Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem","volume":"30","author":"Jawa","year":"2015","journal-title":"J Intensive Care Med"},{"key":"R10-20250123","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0887-7963(96)80121-0","article-title":"Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients","volume":"10","author":"Ohto","year":"1996","journal-title":"Transfus Med Rev"},{"key":"R11-20250123","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3109\/14767058.2014.928859","article-title":"Transfusion-associated graft versus host disease (TAGVHD)-with reference to neonatal period","volume":"28","author":"Gokhale","year":"2015","journal-title":"J Maternal-Fetal Neonat Med"},{"key":"R12-20250123","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-3148.1997.d01-9.x","article-title":"Identification of HLA class II antigens as the targets of effector clones, which may cause transfusion-associated graft-versus-host disease","volume":"7","author":"Nishimura","year":"1997","journal-title":"Transfus Med"},{"key":"R13-20250123","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/stem.140473","article-title":"The immunopathophysiology of acute graft-versus-host-disease","volume":"14","author":"Ferrara","year":"1996","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"R14-20250123","doi-asserted-by":"crossref","first-page":"100792","DOI":"10.1016\/j.blre.2020.100792","article-title":"Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions","volume":"48","author":"Martinez-Cibrian","year":"2021","journal-title":"Blood Rev"},{"key":"R15-20250123","doi-asserted-by":"crossref","first-page":"103405","DOI":"10.1016\/j.transci.2022.103405","article-title":"How does transfusion-associated graft-versus-host disease compare to hematopoietic cell transplantation-associated graft-versus-host disease?","volume":"61","author":"Aizawa","year":"2022","journal-title":"Transfus Apheresis Sci"},{"key":"R16-20250123","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tmrv.2008.09.006","article-title":"Transfusion-associated graft-versus-host disease","volume":"23","author":"R\u00fchl","year":"2009","journal-title":"Transfus Med Rev"},{"key":"R17-20250123","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V98.2.272","article-title":"Survival of transfused donor white blood cells in HIV-infected recipients","volume":"98","author":"Kruskall","year":"2001","journal-title":"Blood"},{"key":"R18-20250123","first-page":"401","article-title":"Human posttransfusion graft-versus-host disease","volume":"45","author":"Brubaker","year":"1983","journal-title":"Vox Sanguinis"},{"key":"R19-20250123","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood-2015-01-620872","article-title":"A systematic review of transfusion-associated graft-versus-host disease","volume":"126","author":"Kopolovic","year":"2015","journal-title":"Blood"},{"key":"R20-20250123","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archpedi.1978.02120280066013","article-title":"Toxic epidermal necrolysis from graft-vs-host disease. Occurrence in a patient with thymic hypoplasia","volume":"132","author":"McCarty","year":"1978","journal-title":"Am J Dis Child (1960)"},{"key":"R21-20250123","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1200\/JCO.2010.29.7978","article-title":"Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101","volume":"28","author":"Lin","year":"2010","journal-title":"J Clin Oncol"},{"key":"R22-20250123","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2141.1994.tb05093.x","article-title":"Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia","volume":"88","author":"Maung","year":"1994","journal-title":"Br J Haematol"},{"key":"R23-20250123","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2141.1995.tb08906.x","article-title":"Transfusion-associated graft-versus-host disease in a patient treated with Cladribine (2-chlorodeoxyadenosine): demonstration of exogenous DNA in various tissue extracts by PCR analysis","volume":"89","author":"Zulian","year":"1995","journal-title":"Br J Haematol"},{"key":"R24-20250123","first-page":"e44148","article-title":"Transfusion-associated graft-versus-host disease in adults","volume":"15","author":"Elmakki","year":"2023","journal-title":"Cureus"},{"key":"R25-20250123","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.1995.tb05311.x","article-title":"Diagnosis of transfusion-associated graft-versus-host disease by polymerase chain reaction in fludarabine-treated B-chronic lymphocytic leukaemia","volume":"91","author":"Briz","year":"1995","journal-title":"Br J Haematol"},{"key":"R26-20250123","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1046\/j.0041-1132.2003.00579.x","article-title":"Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus","volume":"43","author":"Leitman","year":"2003","journal-title":"Transfusion"},{"issue":"(9025)","key":"R27-20250123","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(05)64562-X","article-title":"Hepatitis G-associated aplastic anaemia","volume":"348","author":"Byrnes","year":"1996","journal-title":"Lancet (London, England)"},{"key":"R28-20250123","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bbmt.2014.12.002","article-title":"Increased bacterial infections after transfusion of leukoreduced non-irradiated blood products in recipients of allogeneic stem cell transplants after reduced-intensity conditioning","volume":"21","author":"Jaime-P\u00e9rez","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R29-20250123","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s41409-022-01736-0","article-title":"Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: a multicenter, retrospective study","volume":"57","author":"Holtan","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"R30-20250123","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2004-06-2385","article-title":"Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations","volume":"105","author":"Oh","year":"2005","journal-title":"Blood"},{"key":"R31-20250123","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R32-20250123","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat Rev Dis Prim"},{"key":"R33-20250123","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3324\/haematol.2021.279189","article-title":"One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors","volume":"107","author":"Niederwieser","year":"2022","journal-title":"Haematologica"},{"key":"R34-20250123","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1200\/JCO.2006.08.0952","article-title":"Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10\/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy","volume":"24","author":"Yakoub-Agha","year":"2006","journal-title":"J Clin Oncol"},{"key":"R35-20250123","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1200\/JCO.2008.17.6545","article-title":"Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia","volume":"26","author":"Hahn","year":"2008","journal-title":"J Clin Oncol"},{"key":"R36-20250123","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.transci.2008.03.011","article-title":"Rapid molecular cytogenetic diagnosis of transfusion associated graft-versus-host disease by fluorescent in situ hybridization (FISH)","volume":"38","author":"Akay","year":"2008","journal-title":"Transfus Apheresis Sci"},{"key":"R37-20250123","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-3148.2005.00627.x","article-title":"Diagnosis of transfusion-associated graft-vs.-host disease: the importance of short tandem repeat analysis","volume":"15","author":"Sage","year":"2005","journal-title":"Transfus Med (Oxford, England)"},{"key":"R38-20250123","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.det.2019.05.014","article-title":"Review of graft-versus-host disease","volume":"37","author":"Ramachandran","year":"2019","journal-title":"Dermatol Clin"},{"key":"R39-20250123","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.1537-2995.2002.00253.x","article-title":"Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation","volume":"42","author":"Hutchinson","year":"2002","journal-title":"Transfus"},{"key":"R40-20250123","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1423-0410.1999.7640241.x","article-title":"Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor","volume":"76","author":"Ryo","year":"1999","journal-title":"Vox Sanguinis"},{"key":"R41-20250123","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-3148.1998.00160.x","article-title":"Immunosuppressive effects of chloroquine: potential effectiveness for treatment of post-transfusion graft-versus-host disease","volume":"8","author":"Nishimura","year":"1998","journal-title":"Transfus Med (Oxford, England)"},{"key":"R42-20250123","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/bloodadvances.2018020214","article-title":"GVHD: biology matters","volume":"2","author":"Ferrara","year":"2018","journal-title":"Blood Adv"},{"key":"R43-20250123","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol"},{"key":"R44-20250123","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","article-title":"First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation","volume":"18","author":"Martin","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"R45-20250123","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood.2019000960","article-title":"How I treat steroid-refractory acute graft-versus-host disease","volume":"135","author":"Martin","year":"2020","journal-title":"Blood"},{"key":"R46-20250123","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41375-020-0804-2","article-title":"Treatment and unmet needs in steroid-refractory acute graft-versus-host disease","volume":"34","author":"Malard","year":"2020","journal-title":"Leukemia"},{"key":"R47-20250123","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14728222.2021.1992383","article-title":"New therapeutic targets and biomarkers for acute graft-versus-host disease (GVHD)","volume":"25","author":"Choe","year":"2021","journal-title":"Exp Opin Therap Targets"},{"key":"R48-20250123","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N Engl J Med"},{"key":"R49-20250123","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1111\/trf.16656","article-title":"X- and gamma-irradiation have similar effects on the in vitro quality of stored red cell components","volume":"61","author":"Marks","year":"2021","journal-title":"Transfusion"},{"key":"R50-20250123","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/vox.12558","article-title":"Prevention of transfusion-associated graft-versus-host disease with pathogen-reduced platelets with amotosalen and ultraviolet A light: a review","volume":"112","author":"Cid","year":"2017","journal-title":"Vox Sanguinis"},{"key":"R51-20250123","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/trf.14930","article-title":"Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied intervention","volume":"58","author":"Kleinman","year":"2018","journal-title":"Transfusion"},{"key":"R52-20250123","doi-asserted-by":"crossref","first-page":"103404","DOI":"10.1016\/j.transci.2022.103404","article-title":"Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?","volume":"61","author":"Li","year":"2022","journal-title":"Transfus Apheresis Sci"},{"key":"R53-20250123","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1111\/j.1537-2995.2010.02714.x","article-title":"White blood cell inactivation after treatment with riboflavin and ultraviolet light","volume":"50","author":"Marschner","year":"2010","journal-title":"Transfusion"},{"key":"R54-20250123","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrclinonc.2014.102","article-title":"Current and emerging strategies for the prevention of graft-versus-host disease","volume":"11","year":"2014","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/hemoncstem.HEMONCSTEM-D-24-00043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:46:23Z","timestamp":1787773583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/hemoncstem.HEMONCSTEM-D-24-00043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/hemoncstem.hemoncstem-d-24-00043","relation":{},"ISSN":["1658-3876","2589-0646"],"issn-type":[{"value":"1658-3876","type":"print"},{"value":"2589-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2024-10-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}